Showing results (31-40 of 295) with videos related to
Sort By:
Pageof 30
Endocrine-Related Cancer|January 30, 2007
Targeting of multiple signalling pathways by heat shock protein 90 molecular chaperone inhibitorsMarissa V Powers, Paul WorkmanCell Cycle (Georgetown, Tex.)|January 30, 2009
Targeting CDC37: an alternative, kinase-directed strategy for disruption of oncogenic chaperoningJennifer R Smith, Paul WorkmanCancer Cell|April 13, 2011
Resisting targeted therapy: fifty ways to leave your EGFRPaul Workman, Paul A ClarkeTrends in Pharmacological Sciences|March 27, 2021
A New Chemical Probe Challenges the Broad Cancer Essentiality of CK2Marco P Licciardello, Paul WorkmanCancer Discovery|June 4, 2014
EML4-ALK fusions: propelling cancer but creating exploitable chaperone dependencePaul Workman, Rob van MontfortCurrent Cancer Drug Targets|October 8, 2003
The clinical applications of heat shock protein inhibitors in cancer - present and futureUdai Banerji, Ian Judson, Paul WorkmanCancer Cell|February 28, 2025
Probing cancer with small-molecule tools-Progress and challengesSusanne Müller, Domenico Sanfelice, Paul WorkmanCurrent Topics in Medicinal Chemistry|July 18, 2006
Inhibitors of the HSP90 molecular chaperone: attacking the master regulator in cancerEdward McDonald, Paul Workman, Keith JonesBiomarkers in Medicine|May 19, 2010
Use of pharmacokinetic/pharmacodynamic biomarkers to support rational cancer drug developmentDebashis Sarker, Simon Pacey, Paul WorkmanDrug Discovery Today|January 17, 2012
HSP90 inhibition: two-pronged exploitation of cancer dependenciesJon Travers, Swee Sharp, Paul WorkmanPageof 30